CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph

The Canadian Advanced Therapies Training Institute (CATTI) Inc. recently launched its first in-person training site at the University of Guelph through a partnership with OmniaBio Inc., CCRM and the university. The training program, to begin in summer 2023, will cater to recent post-secondary graduates, industry professionals and companies growing their roster of clean room manufacturing staff.

The fast growth of cell and gene therapies (CGTs) has made it a challenge for the global industry to keep up with talent requirements. This new CGT technical training site will begin to address the industry's critical training needs and represents the first stage of a larger, multi-site training strategy for CATTI.

Previous
Previous

Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy

Next
Next

Insights from the "How I Raised" Event: Navigating Funding in HealthTech